Elderly lymphoma patients may benefit from Geriatric-Guided support

NCT ID NCT07476105

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding geriatric-guided care—including nutritional and physical therapy support—improves quality of life for elderly patients with diffuse large B-cell lymphoma. About 170 patients aged 70 and older who are unfit or frail will receive either this extra support or standard care alongside their chemotherapy. The goal is to see if the personalized approach helps them tolerate treatment better and feel better overall.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Geriatric-guided supportive care (structured geriatric consultation, nutritional and physiotherapy evaluation)
What this could lead to
If successful, this approach could improve quality of life and treatment tolerance for elderly lymphoma patients.
What could go wrong
This is a non-randomized trial with only 170 participants, so results may not apply broadly. The intervention is supportive, not a direct treatment for the cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico

    Avellino, Italy

  • A.O.U. Careggi - S.O.D. Ematologia

    Florence, Italy

  • A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia

    Torino, Italy

  • A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia U

    Torino, Italy

  • A.O.U. Policlinico "Paolo Giaccone" - U.O.C. Ematologia

    Palermo, Italy

  • A.O.U. Senese - U.O.C. Ematologia

    Siena, Italy

  • A.O.U.I. di Verona - U.O.C. Ematologia

    Verona, Italy

  • A.R.N.A.S. "Brotzu" P.O. Businco - S.C. Ematologia e TMO

    Cagliari, Italy

  • A.S.L. Teramo Osp. "Giuseppe Mazzini" - U.O.S. Ematologia

    Teramo, Italy

  • A.S.S.T. Grande Ospedale Metropolitano Niguarda - S.C. Ematologia

    Milan, Italy

  • A.S.S.T. Spedali Civili - S.C. Ematologia

    Brescia, Italy

  • A.S.U. Friuli Centrale - Clinica Ematologica

    Udine, Italy

  • A.U.S.L. I.R.C.C.S. Arcispedale S. Maria Nuova - S.C. Ematologia

    Reggio Emilia, Italy

  • A.U.S.L. di Piacenza Osp. Guglielmo da Saliceto - U.O.C. Ematologia e Centro Trapianti

    Piacenza, Italy

  • A.U.S.L. di Ravenna Osp. S. Maria delle Croci - U.O.C. Ematologia

    Ravenna, Italy

  • Azienda Ospedaliero Universitaria delle Marche - S.O.D. Clinica Ematologica

    Ancona, Italy

  • Azienda Ospedaliero Universitaria di Parma - S.C. Ematologia e C.T.M.O.

    Parma, Italy

  • Azienda USL Toscana Centro - SOS Oncoematologia

    Prato, Italy

  • Fondazione Policlinico Campus Bio-Medico - U.O.C. Ematologia e trapianto di cellule staminali

    Roma, Italy

  • I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati

    Aviano, Italy

  • I.R.C.C.S. Fondazione Cà Granda Ospedale Maggiore Policlinico - S.C. Ematologia

    Milan, Italy

  • I.R.C.C.S. Fondazione San Gerardo dei Tintori - S.C. Ematologia

    Monza, Italy

  • I.R.C.C.S. Istituto Oncologico Veneto - U.O.C. Oncologia 1

    Padova, Italy

  • I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia

    Bari, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.